Histone Methyltransferase SUV39H2 Supports Nasopharyngeal Carcinoma Cell Metastasis by Regulation of SIRT1

被引:1
|
作者
You J. [1 ]
Xue H. [1 ]
Chao C. [1 ]
Zhang Z. [1 ]
Tan X. [1 ]
Wang X. [1 ]
Li H. [1 ]
机构
[1] Department of Otorhinolaryngology, The Third Affiliated Hospital of Soochow University, Jiangsu, Changzhou
关键词
histone methyltransferase; metastasis; nasopharyngeal carcinoma; SIRT1; SUV39H2;
D O I
10.1002/tox.24370
中图分类号
学科分类号
摘要
Nasopharyngeal carcinoma (NPC) is a malignant tumor with high metastatic features originating from the nasopharynx. However, the underlying mechanism of Suppressor of variegation 3–9 homolog 2 (SUV39H2) in NPC remains poorly understood. RT-qPCR was carried out to examine SUV39H2 and SIRT1 expression in NPC tissues and cells. Kaplan–Meier method was utilized to evaluate the association between SUV39H2 level and overall survival. The function of SUV39H2 and SIRT1 in NPC cell viability, metastasis, and apoptosis was tested through CCK-8, transwell, and flow cytometry experiments. Here, it was uncovered that SUV39H2 level was augmented in NPC tissues and cells. Moreover, SUV39H2 expedited NPC cell viability, metastasis, and inhibited apoptosis, while SIRT1 addition reversed these impacts. Besides, SUV39H2 induced H3K9me3 enhancement to repress SIRT1 transcription via binding to SIRT1 promoter. Collectively, our results demonstrated upregulated SUV39H2 aggravated NPC tumorigenesis through SIRT1, which may offer a potential therapeutic target for NPC. © 2024 Wiley Periodicals LLC.
引用
收藏
页码:4974 / 4983
相关论文
共 50 条
  • [31] Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma
    Chiba, Tetsuhiro
    Saito, Tomoko
    Yuki, Kaori
    Zen, Yoh
    Koide, Shuhei
    Kanogawa, Naoya
    Motoyama, Tenyu
    Ogasawara, Sadahisa
    Suzuki, Eiichiro
    Ooka, Yoshihiko
    Tawada, Akinobu
    Otsuka, Masayuki
    Miyazaki, Masaru
    Iwama, Atsushi
    Yokosuka, Osamu
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (02) : 289 - 298
  • [32] RETRACTED ARTICLE: Histone methyltransferase SUV39H2 regulates LSD1-dependent CDH1 expression and promotes epithelial mesenchymal transition of osteosarcoma
    Yingying Miao
    Guifeng Liu
    Lin Liu
    Cancer Cell International, 21
  • [33] Retraction Note: Histone methyltransferase SUV39H2 regulates LSD1-dependent CDH1 expression and promotes epithelial mesenchymal transition of osteosarcoma
    Yingying Miao
    Guifeng Liu
    Lin Liu
    Cancer Cell International, 23
  • [34] The Histone Methyltransferase SUV39H1 Suppresses Embryonal Rhabdomyosarcoma Formation in Zebrafish
    Albacker, Colleen E.
    Storer, Narie Y.
    Langdon, Erin M.
    DiBiase, Anthony
    Zhou, Yi
    Langenau, David M.
    Zon, Leonard I.
    PLOS ONE, 2013, 8 (05):
  • [35] The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase
    Fuks, F
    Hurd, PJ
    Deplus, R
    Kouzarides, T
    NUCLEIC ACIDS RESEARCH, 2003, 31 (09) : 2305 - 2312
  • [36] Histone H3 lysine 9 methyltransferase SUV39H1 is associated with clinical outcome of renal clear cell carcinoma patients
    Meng, Wei
    Cui, Ri
    Haque, Saikh Jaharul
    Croce, Carlo M.
    Chakravarti, Arnab
    CANCER RESEARCH, 2017, 77
  • [37] EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression
    Cattaneo, Francesca
    Nucifora, Giuseppina
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (02) : 344 - 352
  • [38] Histone methyltransferase Suv39h1 regulates hepatic stellate cell activation and is targetable in liver fibrosis
    Kong, Ming
    Zhou, Junjing
    Kang, Aoqi
    Kuai, Yameng
    Xu, Huihui
    Li, Min
    Miao, Xiulian
    Guo, Yan
    Fan, Zhiwen
    Xu, Yong
    Li, Zilong
    GUT, 2024, : 810 - 824
  • [39] SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter
    Shuai, Wendi
    Wu, Jiangxue
    Chen, Shuai
    Liu, Ranyi
    Ye, Zhihua
    Kuang, Chunmei
    Fu, Xiang
    Wang, Gaoyuan
    Li, Yingchang
    Peng, Qihua
    Shi, Wei
    Li, Yizhuo
    Zhou, Qianghua
    Huang, Wenlin
    CANCER LETTERS, 2018, 422 : 56 - 69
  • [40] A two-state activation mechanism controls the histone methyltransferase Suv39h1
    Müller M.M.
    Fierz B.
    Bittova L.
    Liszczak G.
    Muir T.W.
    Nature Chemical Biology, 2016, 12 (3) : 188 - 193